01-01-1970 12:00 AM | Source: Angel Broking Ltd
Dr.Reddy`s launches Albendazol in US By Mr. Yash Gupta, Angel Broking Ltd
News By Tags | #5948 #180 #607 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Below are Quote on Dr.Reddy`s launches Albendazol in US by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd   

 
Dr. Reddy’s Laboratories Ltd. along with its subsidiaries together today announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, 200 mg, approved by the U.S. Food and Drug Administration (USFDA). The Albenza brand and generic had U.S. sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health*. Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two. Albenza is a trademark of Glaxosmithkline.

This is a positive development for the company but we don’t expect it to make any huge difference on Drreddy top line as product sales in the USA market was less.

 

Above views are of the author and not of the website kindly read disclaimer